platinum has been researched along with Astrocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Djinović, V; Grgurić-Sipka, S; Miljković, D; Momcilović, M; Mostarica Stojković, M; Sabo, T; Trajković, V | 1 |
| Djinović, VM; Kaludjerović, GN; Miljković, D; Momcilović, M; Mostarica Stojković, M; Sabo, TJ; Trajković, V | 1 |
2 other study(ies) available for platinum and Astrocytoma
| Article | Year |
|---|---|
Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.
Topics: Animals; Antineoplastic Agents; Astrocytes; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Growth Inhibitors; Ligands; Nitric Oxide; Nitrites; Organometallic Compounds; Platinum; Rats; Ruthenium; Spectrophotometry; Spectrophotometry, Infrared; Time Factors; Tumor Cells, Cultured | 2004 |
Novel platinum(IV) complexes induce rapid tumor cell death in vitro.
Topics: Animals; Apoptosis; Astrocytoma; Brain Neoplasms; Fibrosarcoma; Humans; Mice; Necrosis; Organoplatinum Compounds; Oxidative Stress; Platinum; Tumor Cells, Cultured | 2005 |